LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 11.56 | 771.67 | 1432 | 1280 | 1.1182 | 1.3304 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.78 | 771.67 | 1440 | 1459 | 0.9865 | 0.9706 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.78 | 771.67 | 1590 | 1459 | 1.0892 | 1.1948 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.00 | 771.67 | 1595 | 1585 | 1.0060 | 1.0115 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.00 | 771.67 | 1761 | 1585 | 1.1107 | 1.2127 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.22 | 771.67 | 1714 | 1741 | 0.9843 | 0.9732 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.22 | 771.67 | 1877 | 1741 | 1.0779 | 1.1319 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.44 | 771.67 | 1795 | 1910 | 0.9394 | 0.9066 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.44 | 771.67 | 2020 | 1910 | 1.0571 | 1.0867 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.66 | 771.67 | 1889 | 2141 | 0.8821 | 0.8367 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.66 | 771.67 | 2155 | 2141 | 1.0063 | 1.0086 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.89 | 771.67 | 2005 | 2397 | 0.8362 | 0.7928 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.89 | 771.67 | 2304 | 2397 | 0.9609 | 0.9518 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.11 | 771.67 | 2131 | 2675 | 0.7966 | 0.7618 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.11 | 771.67 | 2507 | 2675 | 0.9372 | 0.9289 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.33 | 771.67 | 2368 | 2939 | 0.8056 | 0.7880 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.33 | 771.67 | 2751 | 2939 | 0.9359 | 0.9325 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.55 | 771.67 | 2516 | 3196 | 0.7871 | 0.7796 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 31.55 | 771.67 | 2890 | 3196 | 0.9040 | 0.9040 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 33.78 | 771.67 | 2704 | 3499 | 0.7727 | 0.7770 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 33.78 | 771.67 | 3093 | 3499 | 0.8838 | 0.8899 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.00 | 771.67 | 2852 | 3884 | 0.7342 | 0.7518 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.00 | 771.67 | 3317 | 3884 | 0.8539 | 0.8690 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.22 | 771.67 | 2995 | 4299 | 0.6966 | 0.7285 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.22 | 771.67 | 3588 | 4299 | 0.8345 | 0.8592 | MN20160304_L01 | N08 |